Approach
We build and capture value from company formation to Global/Asia asset accelerator to public investing with a "business development first" mindset
Our investment model
Incubation/
Early Stage
Panacea currently has incubators and venture builder operations in the US (Boston) and Asia (Shanghai, Singapore, Taipei) to source and advance assets.
We collaborate with research institutes, individual inventors and industry entrepreneurs around the globe.
Global/Asia
Asset Accelerator
In partnership with MNC pharma, we fund strategic collaborations globally and in Asia to advance innovation opportunities in a P&L sparing manner.
Asset/technology partners are afforded the opportunity to expand the value of their platforms and even reach into white space areas guided by MNC pharma.
Acceleration activities are stewarded by Panacea’s dedicated team of translational experts in the US and Asia.
Public investing
By leveraging our venture-like discipline and acumen, we identify public opportunities with significant growth potential.
Investment Scope
We have built significant domain knowledge, network and experience in several key areas; and we continue to follow the science and expand our team aligned to these trends. We predominately invest in therapeutics.